HEADER OXIDOREDUCTASE 04-JAN-08 3BV7 TITLE CRYSTAL STRUCTURE OF DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE IN TITLE 2 COMPLEX WITH NADP AND GLYCEROL. RESOLUTION: 1.79 A. COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXO-5-BETA-STEROID 4-DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE, ALDO-KETO REDUCTASE COMPND 5 FAMILY 1 MEMBER D1; COMPND 6 EC: 1.3.1.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER; SOURCE 6 GENE: AKR1D1, SRD5B1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET28A; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A-AKR1D1 KEYWDS 5-BETA-REDUCTASE; GLYCEROL; AKR1A1, BILE ACID CATABOLISM, DISEASE KEYWDS 2 MUTATION, LIPID METABOLISM, NADP, OXIDOREDUCTASE, STEROID METABOLISM EXPDTA X-RAY DIFFRACTION AUTHOR L.DI COSTANZO,J.DRURY,T.M.PENNING,D.W.CHRISTIANSON REVDAT 6 30-AUG-23 3BV7 1 REMARK REVDAT 5 24-JUL-19 3BV7 1 REMARK REVDAT 4 13-JUL-11 3BV7 1 VERSN REVDAT 3 24-FEB-09 3BV7 1 VERSN REVDAT 2 24-JUN-08 3BV7 1 JRNL REVDAT 1 01-APR-08 3BV7 0 JRNL AUTH L.DI COSTANZO,J.E.DRURY,T.M.PENNING,D.W.CHRISTIANSON JRNL TITL CRYSTAL STRUCTURE OF HUMAN LIVER {DELTA}4-3-KETOSTEROID JRNL TITL 2 5{BETA}-REDUCTASE (AKR1D1) AND IMPLICATIONS FOR SUBSTRATE JRNL TITL 3 BINDING AND CATALYSIS. JRNL REF J.BIOL.CHEM. V. 283 16830 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18407998 JRNL DOI 10.1074/JBC.M801778200 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.236 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.236 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2800 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 63320 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5254 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 114 REMARK 3 SOLVENT ATOMS : 348 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.020 REMARK 3 ANGLE DISTANCES (A) : 0.012 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.024 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.031 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BV7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000045996. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : ROSENBAUM-ROCK MONOCHROMATOR REMARK 200 HIGH-RESOLUTION DOUBLE-CRYSTAL REMARK 200 SI (111) SAGITTAL FOCUSING. REMARK 200 ROSENBAUM-ROCK VERTICAL FOCUSING REMARK 200 MIRROR. REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66774 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3BUR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 5.0 MG/ML AKR1D1, 2.0 MM REMARK 280 NADPH, 2.0 MM 5-BETA-CHOLESTAN-3-ONE, 10.0 MM TRIS (PH 7.4). REMARK 280 PRECIPITANT BUFFER: 0.1 M TRIS (PH 7.0), 10-20% (WT/VOL) PEG REMARK 280 4000, 10% ISOPROPANOL., PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.91300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.59300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.91650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.59300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.91300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.91650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR B 326 C TYR B 326 OXT 0.238 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 49 CA - CB - CG ANGL. DEV. = 11.6 DEGREES REMARK 500 TYR A 219 CA - CB - CG ANGL. DEV. = 17.3 DEGREES REMARK 500 ARG B 9 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B 107 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 PRO B 183 O - C - N ANGL. DEV. = -10.6 DEGREES REMARK 500 TYR B 219 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 ARG B 266 CD - NE - CZ ANGL. DEV. = 10.3 DEGREES REMARK 500 ARG B 266 NE - CZ - NH1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG B 266 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 ARG B 307 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG B 307 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 8 34.94 -145.13 REMARK 500 SER A 220 51.98 39.12 REMARK 500 THR A 224 171.39 78.46 REMARK 500 ASN A 232 82.88 -68.09 REMARK 500 HIS B 8 40.10 -143.43 REMARK 500 ASN B 146 79.04 -150.22 REMARK 500 PHE B 200 74.93 -156.17 REMARK 500 SER B 220 53.43 36.62 REMARK 500 THR B 224 169.40 81.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 3901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 3902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 3991 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 3992 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 3999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BUR RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH NADP AND TESTOSTERONE REMARK 900 RELATED ID: 3BUV RELATED DB: PDB DBREF 3BV7 A 1 326 UNP P51857 AK1D1_HUMAN 1 326 DBREF 3BV7 B 1 326 UNP P51857 AK1D1_HUMAN 1 326 SEQRES 1 A 326 MET ASP LEU SER ALA ALA SER HIS ARG ILE PRO LEU SER SEQRES 2 A 326 ASP GLY ASN SER ILE PRO ILE ILE GLY LEU GLY THR TYR SEQRES 3 A 326 SER GLU PRO LYS SER THR PRO LYS GLY ALA CYS ALA THR SEQRES 4 A 326 SER VAL LYS VAL ALA ILE ASP THR GLY TYR ARG HIS ILE SEQRES 5 A 326 ASP GLY ALA TYR ILE TYR GLN ASN GLU HIS GLU VAL GLY SEQRES 6 A 326 GLU ALA ILE ARG GLU LYS ILE ALA GLU GLY LYS VAL ARG SEQRES 7 A 326 ARG GLU ASP ILE PHE TYR CYS GLY LYS LEU TRP ALA THR SEQRES 8 A 326 ASN HIS VAL PRO GLU MET VAL ARG PRO THR LEU GLU ARG SEQRES 9 A 326 THR LEU ARG VAL LEU GLN LEU ASP TYR VAL ASP LEU TYR SEQRES 10 A 326 ILE ILE GLU VAL PRO MET ALA PHE LYS PRO GLY ASP GLU SEQRES 11 A 326 ILE TYR PRO ARG ASP GLU ASN GLY LYS TRP LEU TYR HIS SEQRES 12 A 326 LYS SER ASN LEU CYS ALA THR TRP GLU ALA MET GLU ALA SEQRES 13 A 326 CYS LYS ASP ALA GLY LEU VAL LYS SER LEU GLY VAL SER SEQRES 14 A 326 ASN PHE ASN ARG ARG GLN LEU GLU LEU ILE LEU ASN LYS SEQRES 15 A 326 PRO GLY LEU LYS HIS LYS PRO VAL SER ASN GLN VAL GLU SEQRES 16 A 326 CYS HIS PRO TYR PHE THR GLN PRO LYS LEU LEU LYS PHE SEQRES 17 A 326 CYS GLN GLN HIS ASP ILE VAL ILE THR ALA TYR SER PRO SEQRES 18 A 326 LEU GLY THR SER ARG ASN PRO ILE TRP VAL ASN VAL SER SEQRES 19 A 326 SER PRO PRO LEU LEU LYS ASP ALA LEU LEU ASN SER LEU SEQRES 20 A 326 GLY LYS ARG TYR ASN LYS THR ALA ALA GLN ILE VAL LEU SEQRES 21 A 326 ARG PHE ASN ILE GLN ARG GLY VAL VAL VAL ILE PRO LYS SEQRES 22 A 326 SER PHE ASN LEU GLU ARG ILE LYS GLU ASN PHE GLN ILE SEQRES 23 A 326 PHE ASP PHE SER LEU THR GLU GLU GLU MET LYS ASP ILE SEQRES 24 A 326 GLU ALA LEU ASN LYS ASN VAL ARG PHE VAL GLU LEU LEU SEQRES 25 A 326 MET TRP ARG ASP HIS PRO GLU TYR PRO PHE HIS ASP GLU SEQRES 26 A 326 TYR SEQRES 1 B 326 MET ASP LEU SER ALA ALA SER HIS ARG ILE PRO LEU SER SEQRES 2 B 326 ASP GLY ASN SER ILE PRO ILE ILE GLY LEU GLY THR TYR SEQRES 3 B 326 SER GLU PRO LYS SER THR PRO LYS GLY ALA CYS ALA THR SEQRES 4 B 326 SER VAL LYS VAL ALA ILE ASP THR GLY TYR ARG HIS ILE SEQRES 5 B 326 ASP GLY ALA TYR ILE TYR GLN ASN GLU HIS GLU VAL GLY SEQRES 6 B 326 GLU ALA ILE ARG GLU LYS ILE ALA GLU GLY LYS VAL ARG SEQRES 7 B 326 ARG GLU ASP ILE PHE TYR CYS GLY LYS LEU TRP ALA THR SEQRES 8 B 326 ASN HIS VAL PRO GLU MET VAL ARG PRO THR LEU GLU ARG SEQRES 9 B 326 THR LEU ARG VAL LEU GLN LEU ASP TYR VAL ASP LEU TYR SEQRES 10 B 326 ILE ILE GLU VAL PRO MET ALA PHE LYS PRO GLY ASP GLU SEQRES 11 B 326 ILE TYR PRO ARG ASP GLU ASN GLY LYS TRP LEU TYR HIS SEQRES 12 B 326 LYS SER ASN LEU CYS ALA THR TRP GLU ALA MET GLU ALA SEQRES 13 B 326 CYS LYS ASP ALA GLY LEU VAL LYS SER LEU GLY VAL SER SEQRES 14 B 326 ASN PHE ASN ARG ARG GLN LEU GLU LEU ILE LEU ASN LYS SEQRES 15 B 326 PRO GLY LEU LYS HIS LYS PRO VAL SER ASN GLN VAL GLU SEQRES 16 B 326 CYS HIS PRO TYR PHE THR GLN PRO LYS LEU LEU LYS PHE SEQRES 17 B 326 CYS GLN GLN HIS ASP ILE VAL ILE THR ALA TYR SER PRO SEQRES 18 B 326 LEU GLY THR SER ARG ASN PRO ILE TRP VAL ASN VAL SER SEQRES 19 B 326 SER PRO PRO LEU LEU LYS ASP ALA LEU LEU ASN SER LEU SEQRES 20 B 326 GLY LYS ARG TYR ASN LYS THR ALA ALA GLN ILE VAL LEU SEQRES 21 B 326 ARG PHE ASN ILE GLN ARG GLY VAL VAL VAL ILE PRO LYS SEQRES 22 B 326 SER PHE ASN LEU GLU ARG ILE LYS GLU ASN PHE GLN ILE SEQRES 23 B 326 PHE ASP PHE SER LEU THR GLU GLU GLU MET LYS ASP ILE SEQRES 24 B 326 GLU ALA LEU ASN LYS ASN VAL ARG PHE VAL GLU LEU LEU SEQRES 25 B 326 MET TRP ARG ASP HIS PRO GLU TYR PRO PHE HIS ASP GLU SEQRES 26 B 326 TYR HET NAP A3901 48 HET GOL A3991 6 HET GOL A3992 6 HET GOL A3999 6 HET NAP B3902 48 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM GOL GLYCEROL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 GOL 3(C3 H8 O3) FORMUL 8 HOH *348(H2 O) HELIX 1 1 GLU A 28 THR A 32 5 5 HELIX 2 2 GLY A 35 GLY A 48 1 14 HELIX 3 3 ALA A 55 GLN A 59 5 5 HELIX 4 4 ASN A 60 GLU A 74 1 15 HELIX 5 5 ARG A 78 ILE A 82 5 5 HELIX 6 6 TRP A 89 HIS A 93 5 5 HELIX 7 7 VAL A 94 GLU A 96 5 3 HELIX 8 8 MET A 97 GLN A 110 1 14 HELIX 9 9 ASN A 146 ALA A 160 1 15 HELIX 10 10 ASN A 172 ASN A 181 1 10 HELIX 11 11 GLN A 202 HIS A 212 1 11 HELIX 12 12 PRO A 237 LYS A 240 5 4 HELIX 13 13 ASP A 241 TYR A 251 1 11 HELIX 14 14 THR A 254 ARG A 266 1 13 HELIX 15 15 ASN A 276 GLN A 285 1 10 HELIX 16 16 THR A 292 ALA A 301 1 10 HELIX 17 17 LEU A 311 ARG A 315 5 5 HELIX 18 18 GLY B 35 GLY B 48 1 14 HELIX 19 19 ALA B 55 GLN B 59 5 5 HELIX 20 20 ASN B 60 GLU B 74 1 15 HELIX 21 21 ARG B 78 ILE B 82 5 5 HELIX 22 22 TRP B 89 HIS B 93 5 5 HELIX 23 23 VAL B 94 GLU B 96 5 3 HELIX 24 24 MET B 97 GLN B 110 1 14 HELIX 25 25 ASN B 146 ALA B 160 1 15 HELIX 26 26 ASN B 172 ASN B 181 1 10 HELIX 27 27 GLN B 202 HIS B 212 1 11 HELIX 28 28 PRO B 237 LYS B 240 5 4 HELIX 29 29 ASP B 241 ASN B 252 1 12 HELIX 30 30 THR B 254 ARG B 266 1 13 HELIX 31 31 ASN B 276 GLN B 285 1 10 HELIX 32 32 THR B 292 ALA B 301 1 10 HELIX 33 33 LEU B 311 ARG B 315 5 5 SHEET 1 A 2 ARG A 9 PRO A 11 0 SHEET 2 A 2 SER A 17 PRO A 19 -1 O ILE A 18 N ILE A 10 SHEET 1 B 8 LEU A 23 GLY A 24 0 SHEET 2 B 8 HIS A 51 ASP A 53 1 O ASP A 53 N LEU A 23 SHEET 3 B 8 PHE A 83 LEU A 88 1 O PHE A 83 N ILE A 52 SHEET 4 B 8 VAL A 114 ILE A 119 1 O ILE A 118 N LEU A 88 SHEET 5 B 8 VAL A 163 SER A 169 1 O LYS A 164 N VAL A 114 SHEET 6 B 8 SER A 191 GLU A 195 1 O GLN A 193 N VAL A 168 SHEET 7 B 8 VAL A 215 TYR A 219 1 O VAL A 215 N ASN A 192 SHEET 8 B 8 VAL A 269 VAL A 270 1 O VAL A 269 N ALA A 218 SHEET 1 C 2 ARG B 9 PRO B 11 0 SHEET 2 C 2 SER B 17 PRO B 19 -1 O ILE B 18 N ILE B 10 SHEET 1 D 8 LEU B 23 GLY B 24 0 SHEET 2 D 8 HIS B 51 ASP B 53 1 O ASP B 53 N LEU B 23 SHEET 3 D 8 PHE B 83 LEU B 88 1 O PHE B 83 N ILE B 52 SHEET 4 D 8 VAL B 114 ILE B 119 1 O ILE B 118 N LEU B 88 SHEET 5 D 8 VAL B 163 SER B 169 1 O SER B 165 N TYR B 117 SHEET 6 D 8 SER B 191 GLU B 195 1 O SER B 191 N VAL B 168 SHEET 7 D 8 VAL B 215 TYR B 219 1 O TYR B 219 N VAL B 194 SHEET 8 D 8 VAL B 269 VAL B 270 1 O VAL B 269 N ALA B 218 SHEET 1 E 2 ALA B 124 PHE B 125 0 SHEET 2 E 2 TYR B 142 HIS B 143 -1 O HIS B 143 N ALA B 124 SITE 1 AC1 26 GLY A 24 THR A 25 TYR A 26 ASP A 53 SITE 2 AC1 26 TYR A 58 LYS A 87 SER A 169 ASN A 170 SITE 3 AC1 26 GLN A 193 TYR A 219 SER A 220 PRO A 221 SITE 4 AC1 26 LEU A 222 GLY A 223 THR A 224 SER A 225 SITE 5 AC1 26 LEU A 239 ALA A 256 ILE A 271 PRO A 272 SITE 6 AC1 26 LYS A 273 SER A 274 PHE A 275 ARG A 279 SITE 7 AC1 26 GLU A 282 ASN A 283 SITE 1 AC2 26 GLY B 24 THR B 25 TYR B 26 ASP B 53 SITE 2 AC2 26 TYR B 58 LYS B 87 SER B 169 ASN B 170 SITE 3 AC2 26 GLN B 193 TYR B 219 SER B 220 PRO B 221 SITE 4 AC2 26 LEU B 222 GLY B 223 THR B 224 SER B 225 SITE 5 AC2 26 LEU B 239 ALA B 256 ILE B 271 PRO B 272 SITE 6 AC2 26 LYS B 273 SER B 274 PHE B 275 ARG B 279 SITE 7 AC2 26 GLU B 282 ASN B 283 SITE 1 AC3 4 ASP A 129 GLU B 103 ARG B 107 ASP B 112 SITE 1 AC4 2 THR A 224 ARG A 226 SITE 1 AC5 5 TYR A 26 THR A 224 SER A 225 ARG A 226 SITE 2 AC5 5 ASN A 227 CRYST1 49.826 109.833 129.186 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020070 -0.000001 -0.000001 0.00000 SCALE2 0.000000 0.009105 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007741 0.00000